RJFSA
IHI icon

Raymond James Financial Services Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Raymond James Financial Services Advisors’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$18.4M Buy
310,663
+17,852
+6% +$1.02M 0.02% 578
2024
Q2 		$16.4M Sell
292,811
-52,404
-15% -$2.93M 0.02% 588
2024
Q1 		$20.2M Sell
345,215
-22,597
-6% -$1.28M 0.03% 504
2023
Q4 		$19.9M Buy
367,812
+71,596
+24% +$3.5M 0.03% 492
2023
Q3 		$14.4M Sell
296,216
-8,759
-3% -$466K 0.03% 564
2023
Q2 		$17.2M Sell
304,975
-17,163
-5% -$945K 0.03% 513
2023
Q1 		$17.4M Sell
322,138
-9,067
-3% -$483K 0.03% 492
2022
Q4 		$17.4M Buy
331,205
+23,111
+8% +$1.17M 0.04% 469
2022
Q3 		$14.5M Sell
308,094
-77,438
-20% -$4.02M 0.03% 485
2022
Q2 		$19.4M Sell
385,532
-100,759
-21% -$5.49M 0.04% 409
2022
Q1 		$29.6M Sell
486,291
-124,340
-20% -$7.41M 0.06% 329
2021
Q4 		$40.2M Sell
610,631
-50,336
-8% -$3.22M 0.08% 261
2021
Q3 		$41.5M Sell
660,967
-30,323
-4% -$1.93M 0.08% 245
2021
Q2 		$41.6M Sell
691,290
-57,354
-8% -$3.32M 0.08% 247
2021
Q1 		$41.2M Sell
748,644
-97,194
-11% -$5.39M 0.09% 219
2020
Q4 		$46.2M Buy
845,838
+181,866
+27% +$9.51M 0.12% 184
2020
Q3 		$33.2M Sell
663,972
-26,868
-4% -$1.3M 0.09% 213
2020
Q2 		$30.5M Buy
690,840
+38,790
+6% +$1.66M 0.1% 220
2020
Q1 		$24.5M Sell
652,050
-41,076
-6% -$1.73M 0.11% 193
2019
Q4 		$30.5M Buy
693,126
+183,516
+36% +$7.71M 0.1% 218
2019
Q3 		$21M Buy
509,610
+72,462
+17% +$2.97M 0.08% 275
2019
Q2 		$17.5M Sell
437,148
-34,212
-7% -$1.29M 0.07% 307
2019
Q1 		$18.2M Buy
471,360
+213,762
+83% +$7.76M 0.08% 295
2018
Q4 		$8.58M Buy
257,598
+528
+0.2% +$18.3K 0.05% 392
2018
Q3 		$9.75M Buy
257,070
+16,614
+7% +$590K 0.04% 431
2018
Q2 		$8.04M Buy
240,456
+81,186
+51% +$2.64M 0.04% 451
2018
Q1 		$4.91M Buy
159,270
+25,998
+20% +$801K 0.03% 553
2017
Q4 		$3.85M Buy
133,272
+14,394
+12% +$415K 0.02% 640
2017
Q3 		$3.31M Buy
118,878
+22,386
+23% +$619K 0.02% 699
2017
Q2 		$2.68M Buy
96,492
+29,490
+44% +$781K 0.02% 752
2017
Q1 		$1.69M Sell
67,002
-5,304
-7% -$129K 0.01% 910
2016
Q4 		$1.6M Buy
72,306
+12,552
+21% +$285K 0.01% 878
2016
Q3 		$1.45M Buy
59,754
+26,988
+82% +$642K 0.01% 897
2016
Q2 		$740K Buy
32,766
+10,782
+49% +$234K 0.01% 1199
2016
Q1 		$449K Buy
+21,984
New +$427K 0.01% 1315

Other funds holding IHI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raymond James Financial Services Advisors's IHI Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its iShares US Medical Devices ETF (IHI) stake by 6.1% in Q3 2024, buying an estimated $1.02M and bringing the position to 310,663 shares worth $18.4M. The position accounts for 0.02% of the portfolio, ranked #578.

Raymond James Financial Services Advisors first reported a position in IHI in Q1 2016 and has held it in 35 quarters since. The position peaked at $46.2M in Q4 2020. 554 funds tracked by Wall St. Rank hold IHI as of Q3 2024.

  • Raymond James Financial Services Advisors held 310,663 shares of iShares US Medical Devices ETF worth $18.4M as of Q3 2024.
  • Raymond James Financial Services Advisors bought 17,852 iShares US Medical Devices ETF shares in Q3 2024, an estimated $1.02M.
  • iShares US Medical Devices ETF made up 0.02% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #578 holding.
  • Raymond James Financial Services Advisors first reported a position in iShares US Medical Devices ETF in Q1 2016 and has held it in 35 quarters since.
  • Raymond James Financial Services Advisors's iShares US Medical Devices ETF position peaked at $46.2M in Q4 2020.
  • 554 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.